Navigation Links
MRI shows disrupted connections in the brains of young people with ADHD

OAK BROOK, Ill. A new study has found that children and adolescents with attention deficit hyperactivity disorder (ADHD) have disrupted connections between different areas of the brain that are evident on resting-state functional magnetic resonance imaging (rfMRI). The results of this research are published online in the journal Radiology.

The findings point to the potential of rfMRI to help provide objectively accurate, early diagnosis of a disorder that affects approximately 5 percent of children and adolescents worldwide.

ADHD is a disorder characterized by age-inappropriate degrees of inattention, hyperactivity and impulsivity. Functional MRI studies, which measure brain activity when a person is focused on a particular task, have implicated the brain's frontostriatal circuit, a collection of neural pathways in the frontal lobe of the brain that helps control behavior. However, the specific brain physiology underlying ADHD remains poorly understood.

For the new study, researchers used rfMRI, a relatively new technique that assesses neural function when the brain is not focused on a specific task. The technique is useful for exploring the brain's functional organization independent of task performance.

The researchers compared rfMRI results in 33 boys with ADHD, ages 6 to 16, with those of 32 similarly aged, healthy controls. They correlated the MRI findings with results from tests of executive function, a term for the set of mental processes involved in planning, organizing, time management and regulating emotions, among other things. People with ADHD often have abnormal executive function.

The results showed that the patients with ADHD had altered structure and function located in areas of the brain like the orbitofrontal cortex, which is primarily involved in the cognitive processing of strategic planning, and the globus pallidus, which is involved in executive inhibitory control.

"Our study suggests that the structural and functional abnormalities in these brain regions might cause the inattention and hyperactivity of the patients with ADHD, and we are doing further analysis on their correlation with the clinical symptoms," said Qiyong Gong, M.D., Ph.D., a neuroradiologist from the Department of Radiology at West China Hospital of Sichuan University in Sichuan, China. "Our preliminary results show the association between imaging findings and symptoms."

The researchers also found abnormalities in the connections between resting-state brain networks associated with executive dysfunction. These abnormalities indicate more widespread brain alterations in ADHD than previously had been shown, Dr. Gong said.

Exploration of the association between brain activity and executive function might be useful in better characterizing patients with ADHD and in understanding the pathophysiology underlying the condition, according to Dr. Gong.

"Our results suggest the potential clinical utility of the rfMRI changes as a useful marker, which may help in diagnosis and in monitoring disease progression and, consequently, may inform timely clinical intervention in the future," he said.

Dr. Gong indicated that larger studies are needed to validate the results. The researchers also plan to study changes in connectivity over time in ADHD patients and explore the potential differences of functional connectivity between the clinical subtypes of ADHD, such as inattentiveness and hyperactivity.

The ADHD study is part of a larger project from Dr. Gong's group at Huaxi MR Research Center of the West China Hospital to explore MRI's diagnostic and prognostic potential in psychiatric disorders.


Contact: Linda Brooks
Radiological Society of North America

Related medicine news :

1. New health system scorecard shows little progress among states from 2007-2012
2. Research shows strategic thinking strengthens intellectual capacity
3. Allina Health study shows information sharing between health systems reduces tests
4. New research shows people are thinking about their health early in the week
5. 20 years of data shows treatment technique improvement for advanced abdominal cancer
6. Experimental drug shows promise for treatment-resistant leukemias
7. Survey shows spine surgeons need to screen more patients for anxiety and depression
8. New human trial shows stem cells are effective for failing hearts
9. Giving steroids during bypass surgery shows no benefit, some harm
10. Cleveland Clinic study shows bariatric surgery provides long-term control of diabetes
11. UEA research shows gastric surgery halves risk of heart attack in obese people
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: